BPC-157对间歇性囊炎患者症状的影响:试点研究
Alternative therapies in health and medicine
|September 26, 2024
概括
身体保护性化合物157 (BPC-157) 在耐托桑聚硫酸盐的患者中有效治疗了间歇性囊炎. 这种注射在一个小型试验中显示出高的成功率和没有不良事件.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 间歇性囊炎 (膀疼痛综合征) 是一种使人虚弱的疾病,治疗选择有限.
- 托桑聚硫酸盐已获得批准,但在一些患者中失败,并具有潜在的副作用.
- 身体保护性化合物157 (BPC-157) 是一种用于治疗间歇性囊炎的试验性.
研究的目的:
- 评估BPC-157在间歇性囊炎的安全性和有效性.
- 评估从503A复合药房获得的BPC-157.
主要方法:
- 十二名患有耐火性间歇性囊炎的妇女接受了一次10毫克BPC-157静脉注射.
- 参与者接受了囊镜检查.
- 通过使用全球响应评估问卷来评估有效性.
主要成果:
- 在12名患者中,有10名患者报告了100%的症状消失.
- 剩下的2名患者报告了80%的症状改善.
- 所有12名患者在全球响应评估中都获得了5/5的分数.
- 没有报告任何不良事件或学.
结论:
- 静脉内注射BPC-157是一种对间歇性囊炎的有希望的治疗方法.
- BPC-157在对托桑聚硫酸盐无反应的患者中表现出高的疗效和安全性.
- 这项研究是首次报告内BPC-157治疗间歇性囊炎的结果.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
143
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
143
Drugs for Treatment of Diarrhea-Predominant IBS
152
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
152
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
2
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
2
Chronic Bowel Disorders: Introduction
408
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
408
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
146
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
146


